Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Randomized Controlled Trial (RCT) of 6 Weeks of Human Growth Hormone (HGH) Prior to Ovulation Induction for In Vitro Fertilization (IVF)

NCT02179255 is registered in ClinicalTrials.gov with Center for Human Reproduction as lead sponsor.

NCT NCT02179255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02179255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Randomized Controlled Trial (RCT) of 6 Weeks of Human Growth Hormone (HGH) Prior to Ovulation Induction for In Vitro Fertilization (IVF)
Lead sponsor
Center for Human Reproduction
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 1, 2014
Completion date
June 30, 2022
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

female infertility due to diminished ovarian reserve